Ciforadenant
CPI-444-001
Phase 1 small_molecule completed
Quick answer
Ciforadenant for Renal Cell Cancer is a Phase 1 program (small_molecule) at Corvus Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Corvus Pharmaceuticals
- Indication
- Renal Cell Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed